Multicultural Marketing

Reach Your Target Audience and Maximize Your Brand’s Impact.

Learn More
mcm1

Multicultural Marketing Consulting for Life Sciences

Your Brand, Your Product, Your Messaging in Their Language

Whether you’re a corporation looking to adapt and target your branding, marketing, and advertising for new markets, or an agency working toward these goals on a client’s behalf, TransPerfect Life Sciences' multicultural marketing solutions help ensure maximum impact for your efforts.

Life Sciences Multicultural Consulting

Successful globalization requires more than just translation—it requires an in-depth understanding of the local culture and regulations. Regardless of the market you’re expanding into, if you’re a healthcare marketing agency, a patient recruitment agency, or life sciences organization, our specialized team of multilingual brand managers and global consultants will keep your brand and product commercialization on track.

Content & Campaign Adaption

Building an effective campaign means hours of work and detailed planning. When you’re expanding globally, adapting every single aspect of your messaging can be a monumental challenge. Ensure that your campaign and content stay true to your core messaging while meeting your launch expectations with expert insights into your target audience and cultural nuances—all while adhering to local market regulations.

Specialized Brand, Marketing, and Advertising Global Consulting for the Life Sciences Industry

Whether you’re entering a new market for the first time or finding ways to improve your global expansion, we have the experience and expertise to help you effectively adapt your product’s messaging to capture the local nuances of any market.

Maximize Your Brand’s Impact

Get a free consultation.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

News and Thought Leadership

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations.

Potential Impact of the EU Biotech Act Proposal on Clinical Trial Activities

The European Commission’s proposed Biotech Act introduces changes that could reshape how clinical trials are approved and managed across the EU. While the broader package spans multiple areas of the health ecosystem, proposed updates to the EU Clinical Trial Regulation (EU CTR) stand out for their potential to address long-standing operational challenges including lengthy timelines, limited flexibility in submissions, and fragmented processes across member states. ...

Potential Impact of the EU Biotech Act Proposal on Clinical Trial Activities

A Checklist for eCOA Solution Deployment: Best Practices and Considerations

Selecting and deploying a new eCOA solution involves many important factors - from determining the capabilities of the Language Service Provider (LSP) to identifying the technology used for each COA migration - and it’s impossible not to worry about missing a key detail in the ...

Fortune 500 Pharma Company Meets Critical Deadlines with TransPerfect Life Sciences’ COA Solutions

This spotlight reviews the challenges faced by a Fortune 500 pharmaceutical company in implementing Clinical Outcome Assessments (COAs) to measure the impact of their products on patients. It discusses the need for accurate and culturally appropriate translations of COAs for ...

Successful English Build & Language Migration

Over the past decade, the global clinical trial landscape has changed drastically. A surge in technological innovation, including wearable devices, patient portals, and apps, has modernized how clinical data is collected and managed. With pen and paper becoming obsolete in the ...

Why 75% of Medical Device Manufacturers Are Disappointed with Their AI Results

The Gap "The results we're seeing from AI are only as good as the data and structure we put behind it. Most manufacturers haven't done that work yet." — Marc Miller, Division President, TransPerfect Medical DeviceArtificial intelligence has arrived in medical device...

Metadata In, Metadata Out: Reducing RIM Submission Rework with In-System Translation

Pharmaceutical companies spend billions and take years to bring therapies to market. Then many risk it all on a translation process managed with spreadsheets, email chains, and blind faith. Every label update, every safety amendment, every regulatory change notice must be...

AI Content Creation and Maintenance in Medical Information: Ending the Content Whack-a-Mole

For many medical information (MI) teams, content maintenance can often feel like a game of whack-a-mole.Update one answer, three more pop up. Fix a regional version, and another channel drifts out of sync. Add a new piece of literature, and suddenly every approved response...